Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Hypertrophy, Right Ventricular

rosiglitazone has been researched along with Hypertrophy, Right Ventricular in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahsan, F; McMurtry, IF; Nozik-Grayck, E; Rashid, J; Stenmark, KR1
Archer, D; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Park, K; Sutliff, RL1
Ambalavanan, N; Bulger, A; Chen, YF; Halloran, B; James, ML; Nicola, T; Olave, N; Oparil, S; Rehan, V; Zhang, W1
Crossno, JT; Dempsey, EC; Garat, CV; Klemm, DJ; McMurtry, IF; Morris, KG; Reusch, JE; Stenmark, KR1

Other Studies

4 other study(ies) available for rosiglitazone and Hypertrophy, Right Ventricular

ArticleYear
Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.
    American journal of physiology. Lung cellular and molecular physiology, 2019, 01-01, Volume: 316, Issue:1

    Topics: Administration, Inhalation; Animals; Drug Therapy, Combination; Heart Function Tests; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sildenafil Citrate; Vascular Remodeling

2019
Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
    American journal of respiratory cell and molecular biology, 2017, Volume: 56, Issue:1

    Topics: Anemia, Sickle Cell; Animals; Blood Pressure; Endothelial Cells; Endothelin-1; Gene Knockdown Techniques; Hemin; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Ligands; Lung; Mice; MicroRNAs; Models, Biological; PPAR gamma; Proto-Oncogene Protein c-ets-1; Pulmonary Artery; Rosiglitazone; Systole; Thiazolidinediones; Up-Regulation

2017
Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.
    American journal of physiology. Lung cellular and molecular physiology, 2011, Volume: 301, Issue:1

    Topics: Airway Remodeling; Animals; Animals, Newborn; Antibodies, Neutralizing; Chronic Disease; Collagen; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice; Mice, Inbred C57BL; PPAR gamma; Pulmonary Alveoli; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta

2011
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling.
    American journal of physiology. Lung cellular and molecular physiology, 2007, Volume: 292, Issue:4

    Topics: Animals; Blood Pressure; Collagen; Elastin; Extracellular Matrix; Female; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; PPAR gamma; Proto-Oncogene Proteins c-kit; Pulmonary Artery; Rats; Rats, Inbred WKY; Rosiglitazone; Thiazolidinediones

2007